AI and ML Get FDA Boost for Drug Trials and Development
The FDA acknowledges that AI/ML is being used more and more in medication development.
In 2021, more than 100 AI/ML contributions were recorded.
Postmarket safety surveillance, clinical research, and drug development are all being transformed by AI/ML.
The FDA is dedicated to supporting innovation while maintaining the safety of pharmaceuticals.
A discussion paper investigating AI/ML in drug development was released.
Read More Stories